NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
A parent drug is the original compound that is ingested, insufflated, or injected, and metabolites are products of the biological breakdown of the parent drug to excrete it from the body. Some metabolites remain active and can potentially have deleterious effects on driving performance until further metabolism is complete. Other metabolites are inactive (i.e., do not affect cognitive or motor functions) but serve as an indicator of recent drug consumption. The time it takes the body to metabolize a substance varies by drug and by the condition of the individual. The presence of an inactive metabolite in the blood indicates the parent drug was used at some time in the past, but for many drugs it is not possible to calculate with any certainty when that exposure occurred.
Unless otherwise stated, the results presented in this report include only parent drugs and active metabolites. The presence of these compounds can be confidently considered an indication that an active form of the drug was detectable in the tested individual at the time of their involvement in the crash or was administered therapeutically after the crash. If a drug positive result could be attributed to therapeutic administration (e.g., there was a record that fentanyl was given by EMS during transport), it was coded as negative in the study analysis despite the possibility the drug was already present (e.g., patient had used fentanyl recreationally) when the crash occurred.
Each individual drug has a generic name and, sometimes, one or more brand/trade names. For studies such as this one, drugs and metabolites can be classified/categorized in a variety of ways. The results reported here use the general drug classes and categories described below.
Alcohol. Alcohol (ethyl alcohol) has well-established impairing effects on psychomotor skills. Alcohol is a central nervous system depressant and affects cognitive and motor functions.
Cannabinoids. Tetrahydrocannabinol (THC) is a natural cannabinoid and the major psychoactive component of cannabis. THC can have a stimulant or sedative effect depending on the individual, and at high doses it may have a hallucinogenic type effect in rare cases. The parent drug delta-9-tetrahydrocannabinol ( $\Delta$ -9-THC or delta-9-THC) and the active metabolite 11-hydroxy- $\Delta$ 9-tetrahydrocannabinol (11-OH-THC or hydroxy-THC) are potentially impairing. 11-nor-9-carboxy- $\Delta$ 9-tetrahydrocannabinol (11-COOH-THC or carboxy-THC) is a downstream metabolic product and does not have known impairing effects. The 11-COOH-THC metabolite could be an indicator of recent use; for heavy users the compound can remain in a person's system for several days or even weeks.
Opioids. Opioids are generally used to treat acute pain. This class of drugs can have negative effects on psychomotor function due to sedation, respiratory depression, fatigue, lightheadedness, and pupillary constriction. Continued use of opioids may allow the body to adapt to the effects via tolerance and a user may experience withdrawal when the ingestion of the drug stops. The initial use period and times of withdrawal have the highest risk for impairment.
Sedatives. Sedatives depress the central nervous system. Several types of drugs including benzodiazepines, barbiturates, muscle relaxants, and sleep aids can be classified as sedatives. Benzodiazepines are prescribed to treat anxiety, seizure disorders, and sleep-related disorders and can cause cognitive and motor function impairments. In addition, benzodiazepines may produce side effects such as weakness, clumsiness, loss of balance, dizziness, and distorted vision. Barbiturates are used to manage anxiety, seizures, migraines, and insomnia. Barbiturates can cause sedation and reduced coordination, but these drugs have largely been replaced therapeutically by benzodiazepines. Muscle relaxants are used to treat muscle spasms or muscle spasticity caused by nervous system disease. These drugs may cause drowsiness, ataxia (poor
18
Keys: ← → or j k turn pages; / finds.